AU731048B2 - Biological material free of viral and molecular pathogens and a process for the production thereof - Google Patents
Biological material free of viral and molecular pathogens and a process for the production thereof Download PDFInfo
- Publication number
- AU731048B2 AU731048B2 AU25612/97A AU2561297A AU731048B2 AU 731048 B2 AU731048 B2 AU 731048B2 AU 25612/97 A AU25612/97 A AU 25612/97A AU 2561297 A AU2561297 A AU 2561297A AU 731048 B2 AU731048 B2 AU 731048B2
- Authority
- AU
- Australia
- Prior art keywords
- biological material
- ligand
- pathogen
- receptor
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
- A61L2/0023—Heat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT780/96 | 1996-04-30 | ||
AT0078096A AT403477B (de) | 1996-04-30 | 1996-04-30 | Biologisches material frei von viralen und molekularen pathogenen und verfahren zur herstellung |
PCT/AT1997/000075 WO1997040861A1 (de) | 1996-04-30 | 1997-04-23 | Biologisches material frei von viralen und molekularen pathogenen und verfahren zur herstellung |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2561297A AU2561297A (en) | 1997-11-19 |
AU731048B2 true AU731048B2 (en) | 2001-03-22 |
Family
ID=3499569
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU25612/97A Ceased AU731048B2 (en) | 1996-04-30 | 1997-04-23 | Biological material free of viral and molecular pathogens and a process for the production thereof |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0900089A1 (de) |
JP (1) | JP2000510107A (de) |
AT (1) | AT403477B (de) |
AU (1) | AU731048B2 (de) |
CA (1) | CA2253300A1 (de) |
IL (1) | IL126810A0 (de) |
NO (1) | NO984979L (de) |
WO (1) | WO1997040861A1 (de) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6617119B2 (en) | 1997-02-21 | 2003-09-09 | The Regents Of The University Of California | Assay for specific strains of multiple disease related conformations of a protein |
US6916419B2 (en) | 1997-02-21 | 2005-07-12 | The Regents Of The University Of California | Device for removal of prions from blood, plasma and other liquids |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6720355B2 (en) | 1997-02-21 | 2004-04-13 | The Regents Of The University Of California | Sodium dodecyl sulfate compositions for inactivating prions |
US6620629B1 (en) | 1997-02-21 | 2003-09-16 | The Regents Of The University Of California | Method for detecting prions |
AU726999B2 (en) * | 1997-06-13 | 2000-11-30 | Baxter Aktiengesellschaft | Process for reducing the concentration of viral and molecular pathogens in a biological material |
DE19752898A1 (de) * | 1997-11-28 | 1999-08-05 | Centeon Pharma Gmbh | Verfahren zum Nachweis hoher Vierenkonzentrationen im Blutplasma und/oder Blutserum mittels der Polymerasekettenreaktion |
US5977324A (en) * | 1998-02-20 | 1999-11-02 | The Regents Of The University Of California | Process for concentrating protein with disease-related conformation |
ATE318176T1 (de) * | 1998-08-31 | 2006-03-15 | Julian L Ambrus | Verfahren zur entfernung von hiv und anderen viren aus blut |
JP2004500350A (ja) * | 1999-12-02 | 2004-01-08 | ブイ アイ テクノロジーズ インコーポレイテッド | 標的分子に対するリガンドを同定する方法 |
AU2002242086A1 (en) * | 2001-02-02 | 2002-08-19 | Chemocentryx, Inc. | Chemomagnetic retrieval of cmv and cmv infected cells |
CN101124315A (zh) | 2003-01-17 | 2008-02-13 | 伊势龙医学股份有限公司 | 利用凝集素亲和性血液透析去除血液中病毒的方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2263781A1 (de) * | 1972-07-13 | 1975-10-10 | Research Corp | |
EP0110407A2 (de) * | 1982-12-02 | 1984-06-13 | Armour Pharmaceutical Corporation | Biologische Produkte frei von Hepatitis-B und nicht-A-nicht-B-Hepatitis |
WO1990015992A1 (en) * | 1989-06-15 | 1990-12-27 | Smith William I Jr | Method and apparatus for inactivating infectious agents in and resisting coagulation of biological fluids |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63243032A (ja) * | 1987-03-27 | 1988-10-07 | Green Cross Corp:The | トロンビンの加熱処理方法 |
ES2131504T3 (es) * | 1990-02-20 | 1999-08-01 | Baxter Int | Trombina humana purificada viricamente segura. |
EP0447984A1 (de) * | 1990-03-20 | 1991-09-25 | Abbott Laboratories | Hyperimmunglobulin gegen Hepatitis-C-Virus und Verfahren zur Herstellung |
DE4125625C2 (de) * | 1991-08-02 | 1999-12-02 | Octapharma Ag Glarus | Verfahren zur Herstellung von virusinaktivierten Immunglobulinlösungen |
DE4142908C2 (de) * | 1991-12-24 | 1994-02-10 | Octapharma Ag Glarus | Verfahren zur Herstellung eines virusinaktivierten Prothrombinkomplex-Konzentrats (PPSB) |
EP0679405A1 (de) * | 1994-04-25 | 1995-11-02 | Rotkreuzstiftung Zentrallaboratorium Blutspendedienst Srk | Verfahren zur Abtrennung von Viren aus Proteinlösungen |
AT406019B (de) * | 1995-05-08 | 2000-01-25 | Immuno Ag | Verfahren zur herstellung eines arzneimittels enthaltend ein oder mehrere plasmaderivate |
-
1996
- 1996-04-30 AT AT0078096A patent/AT403477B/de not_active IP Right Cessation
-
1997
- 1997-04-23 IL IL12681097A patent/IL126810A0/xx unknown
- 1997-04-23 JP JP09538394A patent/JP2000510107A/ja active Pending
- 1997-04-23 EP EP97917167A patent/EP0900089A1/de not_active Withdrawn
- 1997-04-23 AU AU25612/97A patent/AU731048B2/en not_active Ceased
- 1997-04-23 WO PCT/AT1997/000075 patent/WO1997040861A1/de not_active Application Discontinuation
- 1997-04-23 CA CA002253300A patent/CA2253300A1/en not_active Abandoned
-
1998
- 1998-10-26 NO NO984979A patent/NO984979L/no unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2263781A1 (de) * | 1972-07-13 | 1975-10-10 | Research Corp | |
EP0110407A2 (de) * | 1982-12-02 | 1984-06-13 | Armour Pharmaceutical Corporation | Biologische Produkte frei von Hepatitis-B und nicht-A-nicht-B-Hepatitis |
WO1990015992A1 (en) * | 1989-06-15 | 1990-12-27 | Smith William I Jr | Method and apparatus for inactivating infectious agents in and resisting coagulation of biological fluids |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6617119B2 (en) | 1997-02-21 | 2003-09-09 | The Regents Of The University Of California | Assay for specific strains of multiple disease related conformations of a protein |
US6916419B2 (en) | 1997-02-21 | 2005-07-12 | The Regents Of The University Of California | Device for removal of prions from blood, plasma and other liquids |
Also Published As
Publication number | Publication date |
---|---|
AU2561297A (en) | 1997-11-19 |
CA2253300A1 (en) | 1997-11-06 |
NO984979L (no) | 1998-12-23 |
WO1997040861A1 (de) | 1997-11-06 |
JP2000510107A (ja) | 2000-08-08 |
AT403477B (de) | 1998-02-25 |
ATA78096A (de) | 1997-07-15 |
IL126810A0 (en) | 1999-08-17 |
NO984979D0 (no) | 1998-10-26 |
EP0900089A1 (de) | 1999-03-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Burnouf et al. | Nanofiltration of plasma‐derived biopharmaceutical products | |
ES2295308T3 (es) | Procedimiento para la produccion de gammaglobulina g humana inactivada de virus. | |
AU731048B2 (en) | Biological material free of viral and molecular pathogens and a process for the production thereof | |
Parkkinen et al. | A modified caprylic acid method for manufacturing immunoglobulin G from human plasma with high yield and efficient virus clearance | |
Troccoli et al. | Removal of viruses from human intravenous immune globulin by 35 nm nanofiltration | |
JP2008500959A (ja) | ウイルスについて安全な免疫グロブリンの製造方法 | |
RU2008916C1 (ru) | Способ пастеризации водного раствора иммуноглобулина | |
Omar et al. | Removal of neutralized model parvoviruses and enteroviruses in human IgG solutions by nanofiltration | |
Yap | The viral safety of intravenous immune globulin | |
Bos et al. | Virus Validation of PH 4-treated Human Immunoglobulin Produced by the Cohn Fractionation Process | |
CA1066191A (en) | Hepatitis b vaccine | |
Yokoyama et al. | Removal of small non‐enveloped viruses by nanofiltration | |
US6391657B1 (en) | Removal of viruses from protein solutions by ultrafiltration | |
Caballero et al. | Viral safety characteristics of Flebogamma® DIF, a new pasteurized, solvent-detergent treated and Planova 20 nm nanofiltered intravenous immunoglobulin | |
CA2063303C (en) | Preparation of virus-free immunoglobulins | |
Burnouf et al. | Place of nanofiltration for assuring viral safety of biologicals | |
Borovec et al. | Inactivation kinetics of model and relevant blood-borne viruses by treatment with sodium hydroxide and heat | |
Van Holten et al. | Incorporation of an additional viral‐clearance step into a human immunoglobulin manufacturing process | |
Rollag et al. | Viral safety of blood derivatives by immune neutralization | |
US5419906A (en) | Preparation of human immunoglobulin free of hepatitis C | |
JP3735137B2 (ja) | 生物学的活性なタンパク質の溶液における殺ウイルス剤としてのアゾールの使用 | |
Gao et al. | Enhancement in the safety of immune globulins prepared from high-risk plasma | |
SK174799A3 (en) | Process for reducing the concentration of viral and molecular pathogens in a biological material | |
US5159064A (en) | Preparation of virus-free antibodies | |
Burnouf et al. | Strategy of virus removal/inactivation of plasma-derived products: Interest of nanofiltration as a new virus elimination method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FGA | Letters patent sealed or granted (standard patent) | ||
MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |